An engineered miRNA PS-OMe miR130 inhibits acute lung injury by targeting eCIRP in sepsis.
Timothy BorjasAsha JacobMolly KobritzGaifeng MaChuyi TanVihas PatelGene F CoppaMonowar AzizPing WangPublished in: Molecular medicine (Cambridge, Mass.) (2023)
PS-OMe miR130 can be developed as a novel therapeutic by inhibiting eCIRP-mediated inflammation and acute lung injury in sepsis.